SCHEMBL7374322

SCHEMBL7374322

O=C(OCc1ccccc1)N1CCC(c2cc(O)nc(O)n2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.57
NPC1 O15118 2/20 0.57
RAB9A P51151 2/20 0.57
CYP2C19 P33261 1/20 0.55
TRPC3 Q13507 2/20 0.52
TRPC7 Q9HCX4 2/20 0.52
GRIN2B Q13224 7/20 0.50
CYP2D6 P10635 4/20 0.49
CYP2C9 P11712 4/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.48
HSD17B10 Q99714 1/20 0.48
ENPP2 Q13822 1/20 0.48
HTT P42858 1/20 0.47
JAK2 O60674 2/20 0.47
JAK1 P23458 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7376492 0.85 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9ACYP2C19TRPC3
Guanidine SCHEMBL3709856 0.84 SMN1; SMN2 (0.54) SMN1; SMN2NPC1RAB9ACYP2C19TRPC3
SCHEMBL7379278 0.81 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9ACYP2C19TRPC3
SCHEMBL12953168 0.81 SMN1; SMN2 (0.53) SMN1; SMN2NPC1RAB9ACYP2C19TRPC3
SCHEMBL3707829 0.79 SMN1; SMN2 (0.55) SMN1; SMN2NPC1RAB9ACYP2C19TRPC3
SCHEMBL171077 0.79 GRIN2B (0.64) SMN1; SMN2NPC1RAB9ACYP2C19GRIN2B
SCHEMBL16992338 0.78 SMN1; SMN2 (0.58) SMN1; SMN2NPC1RAB9ACYP2C19TRPC3
SCHEMBL4035554 0.78 SMN1; SMN2 (0.72) SMN1; SMN2NPC1RAB9ACYP2C19GRIN2B
SCHEMBL2876671 0.78 ENPP2 (0.49) SMN1; SMN2NPC1RAB9ACYP2C19ENPP2
SCHEMBL13901218 0.77 TRPC3 (0.53) SMN1; SMN2NPC1RAB9ACYP2C19TRPC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6372751-B1 DRUGS WITH BENZENE AND PYRIMIDINE RINGS BERLEX LABORATORIES, INC. 2002-04-16 US disclosed
EP-1135131-A4 ARYL AND HETEROCYCLYL SUBSTITUTED PYRIMIDINE DERIVATIVES AS ANTI-COAGULANTS BERLEX LAB (US) 2002-01-02 EP disclosed
EP-1135131-A1 ARYL AND HETEROCYCLYL SUBSTITUTED PYRIMIDINE DERIVATIVES AS ANTI-COAGULANTS BERLEX LABORATORIES, INC. (US) 2001-09-26 EP disclosed
US-6127376-A A BLOOD FACTOR XA ENZYME INHIBITOR TREATING A HUMAN HAVING A DISEASE-STATE CHARACTERIZED BY THROMBOTIC ACTIVITY BERLEX LABORATORIES, INC. (US) 2000-10-03 US disclosed
WO-2000033844-A1 ARYL AND HETEROCYCLYL SUBSTITUTED PYRIMIDINE DERIVATIVES AS ANTI-COAGULANTS BERLEX LATORATORIES, INC. (US) 2000-06-15 WO disclosed